Chair: Diponkar Banerjee, PHSA Laboratories, Vancouver, British Columbia

Error Reduction and Prevention in Surgical Pathology

Raouf Nakhleh,  

The Role of Histopathology EQA Schemes in Revalidation/Recertification

Raymond McMahon, University of Manchester, Manchester, England 

Change in Management of Medicine

Jared Schwartz, Past-President, College of American Pathologists, Northfield, Illinois 

Future of Cytopathology

Mark Stoler, President, American Society of Clinical Pathologists, Chicago, Illinois 

Chair: Dominique Trudel,

Tele-Pathology

Bernard Tetu, Laval University, Québec, Québec

A casual dinner in a local restaurant will follow.

2000-2200 Concurrent Special Interest Group Sessions S103/S104/S105

Chair: Chris Naugler,

An Introduction to Informatics in Anatomic Pathology

George Yousef, University of Toronto, Toronto, Ontario 

Goals and Objectives of the CAP Informatics Group

Chris Naugler,  

Chair: Pat Shaw ,

Chair: Jason Ford ,

Junior Scientist Award Lecture

Andrew Herzenberg, University Health Network, Toronto General Hospital, Toronto Ontario

2020 Vision of Pathology

Sylvia Asa, University Health Network, Toronto General Hospital, Toronto Ontario

2000-2200 Concurrent Special Interest Group Sessions S301/S302

Chair: Laurette Geldenhuys, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia

Alexander Meisels, Laval University, Quebec, Quebec 

Marc R. Del Bigio, University of Manitoba, Winnipeg, Manitoba 

Chair: Indroit Roy, McGill University, Montreal, Quebec

Developing Anaesthesia Residency Programs in Resource-constrained Settings

Franco Carli, Chair - Canadian Anesthesiologists Society International Educational Foundation 

The African FNA Tutorial Experience: An Ongoing Initiative of the Papanicolau Society of Cytopathology and the College of American Pathologists Foundation

Matthew A. Zarka, Director of Cytopathology, Department Pathology and Lab Medicine, Mayo Clinic, Phoenix/Scottsdale, Arizona 

Break

Pathology in a Resource-poor Environment - a Pilot Project using Cytopathology in PDR Lao

Hallgrimur Benediktsson, Professor of Pathology, University of Calgary, Calgary, Alberta 

Moosa Khalil, Clinical Associate Professor of Pathology, University of Calgary, Calgary, Alberta 

Current State and Future Direction of Pathology Services in Eritrea

Indrojit Roy, Associate Professor, McGill University, Montreal, Quebec 

0800-1030 Concurrent Symposia S501/S502

Chair: Michelle Weir,

Endoscopic Ultrasound Guided Fine Needle Aspiration Biopsy

Richard DeMay, Kulcsar Lecturer, University of Chicago, Chicago, Illinois

Click here for Objectives of this presentation

•  Distinguish among normal, benign, and malignant cells in EUS-FNA;
•  Formulate a differential diagnosis of tumors sampled by EUS-FNA;
•  Formulate a differential diagnosis of cystic pancreatic lesions.
-------------------------------------------

Refreshment Break

presentation continues

Section of Canadian Society of Cytology Annual General Meeting

Chair: Marciano Reis, Sunnybrook Health Sciences Centre, Toronto, Ontario

Molecular Diagnostics: Challenge in Standardization in Funding

Section of Hematopathology Executive Committee Meeting and Annual General Meeting

Chair: Alan Spatz, Jewish General Hospital, McGill University, Montreal, Quebec

Martin Mihm, Massachusetts General Hospital, Boston, Massachusetts

Boris Bastian, Memorial Sloan-Kettering Cancer Center, New York, New York

Refreshment Break

Kevin Watters, Montreal General Hospital, Montreal, Quebec

Chair: Anne O’Brien, St. John Regional Hospital, St. John, New Brunswick

Susan Lester, Brigham and Women’s Hospital, Boston, Massachusetts

Contemporary Reporting and Handling of Breast Cancer Specimens

Anne Marie Mulligan, St. Michael’s Hospital, Toronto, Ontario

Click here for Objectives of this presentation

•  Approach the grossing of breast specimens performed for DCIS in a systematic fashion;
•  List the features of DCIS that will likely impact further management;
•  Summarize the salient features that should be routinely reported for DCIS.
-------------------------------------------

Refreshment Break

Questions & Answers

Section of Anatomic Pathology Annual General Meeting

1400-1700 Concurrent Symposia S801/S802/S803

Chair: Michael Pollanen, University of Toronto and Office of the Chief Coroner of Ontario, Toronto, Ontario

Opening remarks

Michael Pollanen, University of Toronto and Office of the Chief Coroner of Ontario, Toronto, Ontario

DVI: An Introduction

Bruce Prange,

Canadian DVI Teams in Past International Disasters

Michael Pollanen, University of Toronto and Office of the Chief Coroner of Ontario, Toronto, Ontario

DVI in the Aftermath of the Earthquake in Haiti, 2010

Kristopher Cunningham,

Refreshment Break

Forensic Odontology and DVI: Experience in Thailand after the Indian Ocean Tsunami

Bob Wood, University Health Network, Toronto, Ontario

Forensic Anthropology and DVI

Kathy Gruspier,

DVI in Canada: Preparing for the Unthinkable

All 5 symposium presenters will join for a panel discussion

Chair: David Lebrun, Queen’s University, Kingston, Ontario

Personalized Medicine for Cancer Patients: The Critical Role of the Pathologists in the Age of Targeted Therapy

Janet Dancey, Ontario Institute for Cancer Research, Toronto, Ontario

Click here for Objectives of this presentation

•  Describe the emerging role of biomarkers, assays and tests in cancer clinical trials and treatment decisions;
•  Describe the emerging research and clinical practice strategies for personalized medicine for cancer patients;
•  Be familiar with the Canadian cancer clinical trial organizations and their activities.
-------------------------------------------

Refreshment Break

Functional Imaging of Human Tissue Using Automated Quantative Microscopy Methods

Anthony Magliocco, Foothills General Hospital, Calgary, Alberta

Click here for Objectives of this presentation

At the end of the session, the participants will:
•  Understand applications for automated fluorescent IHC;
•  Understand the basis of analytic and post analytic variation in IHC;
•  Understand future directions for automated imaging in cancer pathology.
-------------------------------------------

Impact of EGFR Mutations in Lung Cancer Pathology and Patient Care

Ming Tsao, University of Toronto and UHN, Toronto, Ontario

Click here for Objectives of this presentation

At the end of the session, the participants will understand:
•  The role of EGFR mutations in lung cancer pathology;
•  How EGFR mutations may be determined;
•  The importance of molecular predictive markers in future diagnosis of lung cancer.
-------------------------------------------

Chair: John Maguire, Vancouver General Hospital, Vancouver, British Columbia

Yves Robitaille, University of Montreal, Montreal, Quebec

Refreshment Break

Gliomas: New Diagnostic Tools

Marie-Christine Guiot, Montreal Neurological Institute and Hospital, Montreal, Quebec

Click here for Objectives of this presentation

•  Review the 2007 WHO classification of gliomas (astrocytomas and oligodendrogliomas);
•  Discuss the use of molecular markers in the diagnosis of gliomas and the relevance of the tests in neuro-oncology;
•  Overview the development and implementation of new tests in neuropathology (standardization, quality assurance).
-------------------------------------------

Chair: Raymond Maung,